Novel Echocardiographic Biomarkers Assessing the Myocardial Work in Heart Failure

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 10, 2022

Primary Completion Date

December 10, 2024

Study Completion Date

January 10, 2025

Conditions
Cardiovascular DiseasesHeart FailureValvular Heart DiseaseBiochemical Dysfunction
Interventions
DIAGNOSTIC_TEST

Investigation of clinical profile, laboratory and novel echocardiographic imaging biomarkers

Complete and comprehensive medical interview will be conducted in each eligible patient. In addition, patient's laboratory data will be recorded on admission and pre-discharge. Each patient will undergo a full echocardiographic examination with a specific protocol upon admission and pre-discharge. This will include among others 2-dimensional speckle-tracking analysis of all cardiac chambers, and non-invasive calculation of myocardial work indices of the left and right ventricle.

Trial Locations (1)

54621

RECRUITING

AHEPA University Hospital, Thessaloniki, Greece, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER